ALFA FinderBSE filing, NSE: GUJCMDS. Summary written from the filing by ALFA Finder's alert engine.
ZR2 Bioenergy Ltd: key numbers
- Share price
- ₹133.75
- Market cap
- ₹47.73 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹1.00 Cr
- P/E (TTM)
- 51.9×Sector 28.4×
- Promoter holding
- 61.00%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ZR2 Bioenergy Ltd
All →ZR2 Bioenergy Q1 FY27 Results: Net Profit ₹0.2 Cr, Down 33.3% YoY
ZR2 Bioenergy Ltd reported net profit of ₹0.2 Cr (-33.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.2 Cr · -33.3% YoY
ZR2 Bioenergy Other Announcement
ZR2 Bioenergy Ltd submitted its Monitoring Agency Report for the quarter ending June 30, 2026. The report indicates no fund utilization during this period.
ZR2 Bioenergy Q4 FY26 Results: Net Profit ₹0.2 Cr, Up 100.0% YoY
ZR2 Bioenergy Ltd reported net profit of ₹0.2 Cr (+100.0% YoY) for Q4 FY26.
- Key figure
- Net profit ₹0.2 Cr · +100.0% YoY
ZR2 Bioenergy Financial Results
ZR2 Bioenergy Ltd reported full-year standalone total income of ₹1.84 Crore and net profit of ₹0.70 Crore. Audited results show a significant transition toward bioenergy operations.
- Value
- ₹1.84 Cr
ZR2 Bioenergy Price Movement Clarification
ZR2 Bioenergy Limited clarified that recent significant share price movements are purely market-driven. The company confirmed no undisclosed material information or pending announcements exist.
ZR2 Bioenergy Q3 FY26 Results: Turns Profitable, Net Profit ₹0.2 Cr
ZR2 Bioenergy Ltd reported net profit of ₹0.2 Cr for Q3 FY26.
- Key figure
- Net profit ₹0.2 Cr
Other board meeting date announcements
All →Muzali Arts Board Meeting Date
Muzali Arts has given prior intimation of a board meeting on 14 November 2026 to consider unaudited Q2 and half-year results ended 30 September 2026. The trading window has been closed since 1 October 2026 until 48 hours after results are declared.
Arvaya Healthcare Board Meeting Date
Arvaya Healthcare Ltd intimated a board meeting on November 13, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window remains closed until 48 hours after results are declared.
Aspire & Innovative Advertising Board Meeting Date
Aspire & Innovative Advertising scheduled a November 14, 2026 board meeting to consider unaudited standalone results for the half year ended September 30, 2026. No results figures are attached yet.
SI Capital & Financial Services Board Meeting Date
S.I. Capital will hold a board meeting on 12 November 2026 to consider unaudited standalone quarterly results. This is a prior intimation for the meeting.
Axel Polymers Board Meeting Date
Axel Polymers will hold a board meeting on 13 November 2026 to consider unaudited half-year results. The trading window stays closed until 48 hours after results.
FlySBS Aviation Board Meeting Date
FlySBS Aviation has scheduled a board meeting for 11 November 2026 to consider unaudited half-yearly results for the period ended September 2026. The trading window is not closed.